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Abstract
Background
Diagnosis and treatment for Rheumatic Heart Disease (RHD) is inaccessible for many of
the 33 million people in low and middle income countries living with this disease. More
knowledge about risk factors and pathophysiologic mechanisms involved is needed in order
to prevent disease and optimize treatment. This study investigated risk factors in a Nepalese
population, with a special focus on Vitamin D deficiency because of its immunomodulatory
effects.
Methods
Ninety-nine patients with confirmed RHD diagnosis and 97 matched, cardiac-healthy con-
trols selected by echocardiography were recruited from hospitals in the Central and Western
region of Nepal. Serum 25(OH)D concentrations were assessed using dried blood spots
and anthropometric values measured to evaluate nutritional status. Conditional logistic
regression analysis was used to define association between vitamin D deficiency and RHD.
Results
The mean age of RHD patients was 31 years (range 9–70) and for healthy controls 32 years
(range 9–65), with a 4:1 female to male ratio. Vitamin D levels were lower than expected in
both RDH and controls. RHD patients had lower vitamin D levels than controls with a mean
s-25(OH)D concentration of 39 nmol/l (range 8.7–89.4) compared with controls 45 nmol/l
(range 14.5–86.7) (p-value = 0.02). People with Vitamin D insufficiency had a higher risk
(OR = 2.59; 95% CI: 1.04–6.50) of also having RHD compared to people with Vitamin D
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concentrations >50 nmol/l. Body mass index was significantly lower in RHD patients (22.6;
95% CI, 21.5–23.2) compared to controls (24.2; 95% CI, 23.3–25.1).
Conclusion
RHD patients in Nepal have lower Vitamin D levels and overall poor nutritional status com-
pared to the non-RHD controls. Longitudinal studies are needed to explore the causality
between RHD and vitamin D level. Future research is also recommended among Nepali
general population to confirm the low level of vitamin D as reported in our control group.
Introduction
Rheumatic heart disease (RHD) affects an estimated 33 million people globally [1, 2], making
it the most commonly acquired heart disease in people<25 years and almost as prevalent as
human immunodeficiency virus [3]. Although the incidence of RHD in high-income countries
decreased markedly during the 20th century, it remains a major public health concern in
many low-and middle-income countries and marginalized communities in high-income
countries–as such, three out of four children <15 years grow up in parts of the world where
RHD is endemic [1].
RHD is characterized by chronic valvular lesions and is the result of Acute Rheumatic
Fever (ARF), which develops as an autoimmune response to Group A Streptococcal (GAS)
infection [4]. Currently, there is no curative treatment. The secondary prophylaxis consisting
of benzathine penicillin G injections every 3–4 weeks is used to prevent recurrences, which
can lead to new valvular lesions or to worsening of the previous one [5].
Despite knowing the etiologic agent, there are still many unanswered questions regarding
pathophysiologic mechanisms involved in disease development and progression. The presence
of residual autoreactive cells appears to play a role in the persistence and worsening of the val-
vular lesions in RHD patients [6, 7]. Not all GAS are rheumatogenic, and not all people are sus-
ceptible to developing ARF and RHD. While it is not known what makes a host susceptible
[8], it is generally accepted that malnutrition has a great impact on the immune system affect-
ing both innate and acquired immunity in children [9]. More specifically, hypovitaminosis D
has been associated with an increased risk of infections such as GAS pharyngitis as well as the
risk of developing autoimmune diseases [10, 11]. Links have also been demonstrated with
ARFand rheumatic mitral stenosis [12, 13].
Finally, extravasation through the valvular endothelium seems to be an important step in
the valvular lesions seen in RHD, and since s-25(OH)D regulates expression of vascular endo-
thelial growth factor, this could explain the link between hypovitaminosis D and endothelial
dysfunction, and subsequently ARF and RHD [14, 15].
Nepal is situated in a region with one of the highest prevalence rates of RHD in the world
[2]. A school-based study estimated prevalence of subclinical RHD to be 10.2 per 1000 children
[16]. Prevalence estimates for adults are not available from Nepal, despite peak prevalence usu-
ally occuring between 25–45 years of age. Nonetheless, RHD remains endemic in Nepal and
the South-Asian region. Prevalence of insufficient Vitamin D levels in Nepal vary from 59.8%
amongst new mothers to 17.2% in 6-8year olds [17, 18]. In healthy school-children in neigh-
boring India, vitamin D deficiency prevalence is estimated to 35% [19]. To date, nutritional
status in ARF/RHD patients in Nepal is unknown.
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In this study we examined possible associations between s-25(OH)D levels and RHD status
in Nepal. In addition, associations between socioeconomic factors and RHD is also
investigated.
Methods and materials
Study design and area
This case-control study was carried out in the two largest cities in Nepal, Kathmandu and
Pokhara, which are located in the Central and Western region of the country. Study partici-
pants were recruited from two hospitals; Western Regional Hospital (WRH) in Pokhara and
Manmohan Cardiothoracic Vascular and Transplant Center (MCVTC) in Kathmandu,
between March and July 2018. Both are governmental run health facilities, and have provided
free prophylactic treatment to RHD patients through the national RHD control program
funded by the Nepalese government from 2007 to 2018. MCVTC also provides free cardiac
surgery for RHD patients, approximately 300 cases annually. The institutions are two of the
largest governmental run health facilities in the country, and hence receive patients from all
regions and districts.
Subjects
Cases were selected from registries under the National ARF/RHD Prevention and Control
Program when patients were seen for delivery of secondary prophylaxis, diagnostic and fol-
low-up clinical evaluation or for surgical intervention. Patients were included based on a con-
firmed diagnosis of RHD by echocardiographic screening leading to registration in the
national RHD Program Registry or new echocardiographic findings confirming RHD diagno-
sis, both in accordance with the World Heart Federation echocardiographic guidelines [5].
Exclusion criteria were issues which could interfere with Vitamin D metabolism or with the
immunological conditions such as; patients below five years of age, recent hospitalization for
more than one week, burn victims, chronic kidney disease and current tuberculosis or thyroid
disease (self-reported).
Controls were selected by echocardiography and self-reported medical history among any
people attending either institution as patients, relatives or acquaintants, matched on sex and
age (maximun difference of 5 years). Exclusion criteria of controls were: diagnosis of ARF,
RHD, congenital heart disease, any echocardiographic findings of valvular damage and other-
wise the same exclusion criteria as for cases. Patients with congenital heart disease were
excluded as they can display abnormal vitamin D concentrations [20, 21]. Cases were matched
with controls from the same institution as themselves.
Collection of socio-demographic information
Face-to-face interviews were conducted with all participants using a structured questionnaire
containing questions on household items and living circumstances (S1 File). Socioeconomic
status was assessed by computing a wealth index using principal components analysis. This
divided the participant into terciles; poorest, middle and richest. The components used in the
wealth index were; ownership of a house, animals, vehicles and electronic equipment (electric-
ity, radio, television, mobile phone, telephone, refrigerator), furniture (bed, sofa, cupboard,
computer, table, chair, clock, fan, dhiki/janto), housing characteristics and fuel used for cook-
ing. Thus, this study measures SES based on durable assets ownership and access to utilities, to
accommodate the often very fluctuating income patterns seen in many low and middle inco-
mecountries, including Nepal.
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A food frequency questionnaire was also included (S1 File). Participants were asked to tick
the number of times they had consumed the most commonly available fruit and meat, fish,
soybean oil, and egg in the last week. The purpose of the fruit intake was to detect differences
in variance of diet between cases and controls, and thus give an idea of the general nutritional
state of the two groups. Questions regarding meat, fish, soybean oil, and egg were added due
to their possible direct effect on vitamin D concentrations and RHD development, making an
assessment of differences between the two groups of interest. Questions used in this study are
adapted from the Nepal Demographic and Health Survey [22] and Piryani et al. [23] to ensure
cultural appropriateness.
Anthropometric measurements
The following anthropometric measurements were determined: weight (kg), height (cm), age
(years) and Mid-upper arm circumference (MUAC) (mm). The same weight scale and meter
tape were used to measure cases and controls and measurements were performed by the same
person. Shoes and heavy items of clothing were removed beforehand. Body mass index (BMI)
was calculated as weight in kilogram divided by height squared in meter (kg/m2). MUAC was
measured on the non-dominant/left arm, except in patients with left-sided hemiplegia. Mea-
surement was done at the mid-point between the olecranon and acromion on a relaxed arm.
All participants were checked for pitting edema.
Biochemical measurements
Blood was collected as dried blood spots on Perkin Elmer 226 Five Spot RUO Card filter
paper, and extracted samples analyzed at the Department of Clinical Biochemistry, Aarhus
University Hospital. We measured serum 25-hydroxyvitamin D2 (25(OH)D2, ergocalciferol)
and serum 25-hydroxyvitamin D3 (25(OH)D3, cholecalciferol) using liquid chromatography-
tandem mass spectrometry on Sciex Triple Quad 5500 LCMSMS System calibrated using
25-OH-Vitamin D3/D2 Serum calibration standards (ChromSystems). The method is adapted
from Kvaskoff et al. [24], and S-25(OH)D is expressed as the sum of 25(OH)D2 and 25(OH)
D3. Vitamin D deficiency was divided into three categories following Danish national stan-
dards, defined as: Vitamin D insufficiency (VDI) as a serum concentration between 25–50
nmol/L, moderate vitamin D deficiency (VDD) as a serum concentration of 13–25 nmol/L
and severe Vitamin D deficiency as concentrations <13 nmol/L. For some analysis the term
hypovitaminosis was used, defined as all concentrations < 50 nmol/l.
Sample size
The prevalence of s-25(OH)D levels below 50 nmol/l was set to 77% in RHD patients based on
previous studies [12]. Since data on vitamin D deficiency in Nepal is very inconsistent, we
hypothesized hypovitaminosis D prevalence in non-RHD individuals to be 35%, based on
results from a large study from Northern India [19]. We estimated sample size for two inde-
pendent proportions with a 95% confidence level, 90% power and a margin of error (alpha)
5% to be 64; 32 cases and 32 controls.
Statistical analysis
Data were collected in hard copies and entered using REDCap electronic data capture tools.
Statistical analysis was performed using Stata Statistical Software IC 15.1 (StataCorp LP, TX).
Two-tailed p-values p� 0.05 were considered statistically significant.
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Normality in distribution was tested using q-q plots. Normally distributed continuous vari-
ables were compared between groups using Student’s t-test and reported as means with stan-
dard deviation (SD). Differences between groups of categorical variables were compared using
Chi-square test. SES was calculated by creating wealth index scores for each participant using
principal components analysis (PCA), following the Measuring Equity with Nationally Repre-
sentative Wealth Quintiles guide [25]. Due to the smaller sample size in this study compared to
large epidemiological surveys, quintiles were converted into terciles. Multivariate conditional
logistic regression analysis between sufficient Vitamin D concentrations and hypovitaminosis
D were performed, adjusting for potential confounders; age, sex, BMI, education, and SES
[26–32]. Potential confounders were identified a priori through a literature review. Paired 1:1
matching between cases and controls was performed after data collection, except 5 cases and 1
control who were 2:1 matched, because of the post hoc exclusion of 12 subjects (Fig 1). A sensi-
tivity analysis of available variables before and after excluding the 12 subjects revealed no dif-
ference in major (or other) variables.
Ethical considerations
This study received ethical approval from the ethical review board of the Nepal Health
Research Council (ref. no. 2398). Written information was handed out to participants and rel-
atives in Nepal’s official language Nepali. Prior to data collection, an informed consent form
had to be signed. If illiterate, oral information was given and fingerprint was used as signature.
Informed assent form was obtained from participants under 18 years of age. After biochemical
analysis, all results were reported back to the participants along with advice of treatment if
needed. This was done by local health personnel in Nepali language.
Results
A flowchart illustrating exclusions for the different steps in data analysis is illustrated in Fig 1.
The study excluded 6 cases because they were misclassified as having RHD when in fact their
echocardiography report revealed no significant disease. Later, an additional 6 people were
excluded before any analysis regarding s-25(OH)D concentrations were performed because
these 6 had comorbidities assessed to potentially affect their s-25(OH)D concentrations. They
could still be part of SES calculation, dietary intake, and other demographic measures since
their comorbidities would not influence these parameters.
In total, 99 patients with confirmed RHD diagnosis and 97 matched controls were included
from two different sites in Nepal. A comparison of unadjusted sociodemographic, anthropo-
metric and socioeconomic differences is presented in Table 1.
The mean age of all participants was 31.71 years ± 11.5 and 75.5% were female. There was
no significant difference between cases and control on gender and age.
BMI was significantly lower in cases than in controls, 22.4 ±4.5 kg/m2 and 24.2 ±4.6 kg/m2,
respectively. Mean MUAC for cases were 253 ±34 mm and 266 ±43 mm for controls.
Almost half (47%) of cases belonged to the lowest possible SES class. For controls, this num-
ber was 21%. In the highest SES class, 25% of cases were represented compared to 40% of con-
trols. The cases did not differ significantly on any other sociodemographic variables including
overcrowding, compared to their controls.
We observed VDI and VDD in 78% of cases and mean concentration was significantly
lower compared to controls. The prevalence of VDI and VDD in controls were 70%. Fig 2 dis-
plays the distribution of s-25(OH)D concentrations in all groups.
Univariate conditional logistic regression analysis revealed only association between Vita-
min D deficiency (<25 nmol/l) and RHD (OR = 3.14; 95% CI: 1.02–9.64) but not for Vitamin
PLOS ONE Evaluating Vitamin D levels in Rheumatic Heart Disease
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D insufficiency. However, after adjusting for potential confounders, multivatiate analysis
found a significant association (OR = 2.59; 95% CI: 1.04–6.50) for Vitmain D insufficiency but
a non significant association for Vitamin D deficiency (Table 2).
Detailed echocardiography report was available from 41 patients. Upon Chi-squared test of
the report from the 41 patients available, there was no correlation between the disease stage
Fig 1. Flowchart of inclusions and exclusions.
https://doi.org/10.1371/journal.pone.0237924.g001
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Table 1. Sociodemographic characteristics of cases and controls.
RHD Patients [n = 99] Controls [n = 97] P for difference
Female % 77% 71% 0.500
Age (y), n (%)
5–19 13 (13) 12 (12)
20–29 28 (28) 28 (29)
30–39 40 (41) 36 (37)
40–49 10 (10) 12 (12)
>50 8 (8) 9 (10)
0.976
Mean age (y) ±SD 31 ± 11.4 32 ± 11.6 0.700
Mean BMI (kg/m2) ±SD 22.2 ± 4.4 24.2 ± 4.6 0.002
Mean MUAC mm ± SD 252 ± 34 266 ± 43 0.013
Socioeconomic status, n (%)
Poorest 46 (47) 20 (21)
Middle 27 (28) 38 (39)
Richest 25 (25) 39 (40)
0.001
Number of siblings mean ± SD 4.2 ± 2.4 3.8 ± 2.1 0.300
Sisters 2.3 ± 2.0 1.9 ± 1.5 0.120
Brothers 1.8 ± 1.4 1.9 ± 1.4 0.770
Sleeping arrangement
Bed 83 82
Blanket/mattress on floor 14 15
0.959
People sleeping in same room (overcrowding)
1–2 14 15
3–6 82 79
7–10 2 3
0.867
Heart disease in family 11 11
RHD 5 5
CHD 2 0
Other 4 6
0.301
ARF in family 10 15 0.590
Family type
Nuclear 29 34
Joint 61 60
0.789
Mean s-25(OH)D (range) [n] 38.7 (8.7–89.4) [97] 44.7 (14.5–86.7) [93] 0.014
Characteristics of 99 rheumatic heart disease patients and 97 controls. SD: Standard Deviation; BMI: body-mass-index, kg/m2; MUAC: middle-upper-arm
circumference, mm; RHD: rheumatic heart disease; CHD: congenital heart disease; RF: rheumatic fever.
https://doi.org/10.1371/journal.pone.0237924.t001
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and lower s-25(OH)D concentrations. The same was applicable when the patients without
detailed echocardiographic reports were distributed into the s-25(OH)D categories considered
sufficient, VDI and VDD and showed the same pattern of distribution.
Analysis of the food-frequency questionnaire revealed no statistically significant differences
in intake between cases and controls (Table 3).
Discussion
Both RHD patients and controls in Nepal have a high prevalence of vitamin D deficiency and
insufficiency. RHD patients on average have a significantly lower s-25(OH)D concentration
compared to their controls. Especially, the prevalence of VDD was higher in RHD patients.
This is to date the largest study on Vitamin D and RHD. Three other studies have examined
the relationship between vitamin D concentrations and RF or RHD [12, 13, 33]. The previous
studies showed a 27–59% lower concentration in patients whereas we only demonstrated a
Fig 2. Distribution of s-25 (OH)D concentrations. (A) Distribution of s-25(OH)D concentrations in cases and controls with mean and standard
deviation. (B) Distribution of rheumatic heart disease patients and healthy controls with severe Vitamin D deficiency (<12 nmol/l), Vitamin D
deficiency (12–25 nmol/l), Vitamin D insufficiency (25–50 nmol/l) and sufficient (>50 nmol/l) s-25(OH)D levels.
https://doi.org/10.1371/journal.pone.0237924.g002
Table 2. Odds ratio of rheumatic heart disease diagnosis in relation to s-25(OH)D status.
Unadjusted Adjusteda
OR 95% CI P value OR 95% CI P value
s-25(OH)D >50 nmol/l Reference Reference
s-25(OH)D 50–25 nmol/l 1.61 0.78–3.33 0.20 2.59 1.04–6.50 0.04�
s-25(OH)D <25 nmol/l 3.14 1.02–9.64 0.05� 3.62 0.93–14.09 0.06
� Statistically significant p-values.
a Adjusted for: age, BMI, sex, education, and SES.
Unadjusted (left) and adjusted (right) Odds Ratio of RHD diagnosis in relation to s-25(OH)D status. Sufficient Vitamin D status used as a reference value.
https://doi.org/10.1371/journal.pone.0237924.t002
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12.9% difference. However, Yusuf et al. only included RHD patients, no healthy controls, and
only looked at calcification (Wilkins calcium score) of exclusively stenotic mitral valves [33].
Onan et al. only included patients with rheumatic mitral stenosis [13] and the third study only
included ARF patients and none with RHD [12]. Since inclusion criteria vary between studies,
it is not surprising that results also vary. Worth noting is the fact that they all have the same
conclusion: s-25(OH)D is significantly lower in patients with RHD. However, it is not possible
to report on the causality of this relationship. Vitamin D status can change throughout time,
making it difficult to say if the lower concentration was present before the patient developed
RHD. For instance, the chronically ill RHD patient may not be active and going outside as
much as before falling ill, thus being less exposed to sunlight which might explain a lower s-25
(OH)D concentration. To address these questions a longitudinal study is required. Unfortu-
nately, such data is not available from the study area, and current status is here accepted as a
compromise.
Table 3. Dietary intake in the last week stratified by cases and controls.
RHD patients Controls P value
Fruit intake, n (%)
Not consumed 19 (19) 11 (11)
1 time/week 7 (7) 14 (15)
2–6 times/week 47 (48) 46 (47)
> 7 times/week 26 (26) 26 (27)
0.216
Meat, n (%)
Not consumed 10 (10) 7 (7)
1 time/week 37 (38) 35 (36)
2–6 times/week 44 (45) 46 (47)
> 7 times/week 7 (7) 9 (10)
0.832
Egg, n (%)
Not consumed 30 (31) 27 (28)
1 time/week 26 (26) 19 (20)
2–6 times/week 32 (33) 41 (42)
> 7 times/week 10 (10) 10 (10)
0.503
Soybean Oil, n (%)
Not consumed 44 (45) 40 (41)
1 time/week 8 (8) 3 (3)
2–6 times/week 19 (19) 18 (19)
> 7 times/week 27 (28) 36 (37)
0.287
Fish, n (%)
Not consumed 59 (60) 62 (64)
1 time/week 30 (31) 25 (26)
2–6 times/week 9 (9) 10 (10)
> 7 times/week 0 (0) 0 (0)
0.750
Dietary intake in last one week, in rheumatic heart disease patients and controls.
https://doi.org/10.1371/journal.pone.0237924.t003
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To make sense of these findings, an understanding of the pleiotropic nature of Vitamin D is
important. Vitamin D receptors (VDR) and the activating enzyme 1α-hydroxylase are identi-
fied in over 30 target organs including many cells of the immune system [34]. In the innate
immune system, vitamin D enhances macrophages’ phagocytic abilities and monocytes
increase expression of 1α-hydroxylase and VDR through toll-like receptor signaling when
encountering pathogens. The VDR complexes, in turn, activate transcription of antimicrobial
cytokines [10]. Vitamin D also affects the adaptive immune system by modulation of antigen
presenting cells to a more immature state, expressing fewer major histocompatibility complex
class II molecules and thereby presenting fewer antigens and producing less interleukin-12,
resulting in reduced activation of B and T cells. Furthermore, the modulated antigen present-
ing cells produce more interleukin-10—a tolerogenic cytokine [35]. Altogether, Vitamin D
enhances the body’s resistance against infections while decreasing the risk of an inappropriate
autoimmune response. In general, RHD patients to a greater extent suffer from malnutrition
with both lower BMI and MUAC. Whether they were malnourished before becoming ill or
malnourished because they were ill, is not possible to determine from this study. It could be
part of a two-way causal relationship as undernutrition lower immune responses, thereby
increasing the risk of infection, and infection consequently aggravating undernutrition by an
increase in demands of nutrients while simultaneously decreasing appetite in the affected indi-
vidual [9].
Overcrowding and social disadvantage are two of the most commonly reported risk factors
for GAS infection leading to the first espisode of ARF in susceptible individuals as well as
resulting in recurrences in RHD patients [36]. This study also demonstrated a clear association
between low SES and RHD but did not find an association with overcrowding. This could be
because the mean age of patients was 31 years. Since the first acute episode of ARF occurs
more frequently in the age group of 5–14 years [37], this means their housing situation could
have changed since their childhood and adolescent years when overcrowding contributed for a
higher risk of exposure to GAS and triggered ARF in those susceptible individuals. On the
other hand, in Nepal, it is not unusual to live as a joint family throughout life, as demonstrated
in Table 1.
We found slightly higher s-25(OH)D concentrations in samples collected from MCVTC
compared to samples from WRH. However, geographical plottings showed that participants
from both institutions represent both central and peripheral districts, and the difference
between patients and controls was still present when comparing the groups within the two
institutions.
No association was found between dietary intake and RHD (Table 3). This is in contrast to
the general acceptance of fish and meat products as an important source of Vitamin D [38], as
well as previous studies where consumption of soybean oil and egg, has been shown to sup-
press the rheumatic process because of their high concentrations of phospholipids and palmi-
tamide [39].
Finally, we would like to highlight that the majority of RHD patients were young women.
Though not surprising, it is still an important aspect that raises concern especially since the
age of the women coincides with childbearing age. Having a heart disease, including RHD,
whilst becoming pregnant can lead to serious complications [40]–particularly when access to
health care is limited. In fact, RHD has been suggested a leading cause of indirect obstetric
death in some sub-Saharan countries [30]. Yet no one has been able to explain why women are
more often affected by RHD than men [27, 28, 30]. It is worth noting that this difference is not
present when comparing ARF prevalence. Explanations to this sex-based difference could
include extrinsic factors such as reduced access to primary and secondary ARF prophylaxis for
girls and culturally rooted disadvantages affecting female health in general. Additionally,
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intrinsic factors increasing host susceptibility such as immunogenic, genetic and in particular
hormonal differences, should also be considered and investigated further.
This study has some limitations. The major limitation being the usage of current vitamin D
status as a proxy for previous concentrations. Furthermore, the higher than expected preva-
lence of hypovitaminosis D in the background population reduces the power of the study.
However, the impact was limited by including 3 times as many participants than required in
the sample size calculations. Nonetheless, the sample size is relatively small. This should also
be considered when understanding the measurement of associations. While some are statisti-
cally significant, they are largely marginal. This reduces the immediate clinical applicability of
the results, but should be seen in light of the aforementioned smaller sample size. Increasing
the sample size for future studies could help make the associations clearer.
The dried blood spot sampling procedure for vitamin D concentration was validated twice–
once before and once after data collection—at Aarhus University Hospital, using the exact
same method as in this study, hence the sampling procedure should not be a considerable
source of error. Furthermore, all anthropometric data were measured upon inclusion and not
self reported or taken from previous examinations, adding value to the results.
However, the lack of systematic record keeping in the Nepalese health system made identifi-
cation of comorbidities a challenge. All participants were questioned about their medical his-
tory and whenever possible, their record books were examined thoroughly, but on many
occasions, the patients did not bring their record books, which could result in underreporting
of comorbidities that might affect s-25(OH)D concentrations. Additionally, there is a risk of
recall bias when conducting a survey, especially the food frequency intake should be inter-
preted with caution.
In light of the abovementioned limitations and the very nature of the study design, we sug-
gest caution when generalizing to other populations, but instead advise more research in the
field of vitamin D deficiencies especially in low income countries, and how it affects immune
responses.
Conclusion
Both Vitamin D Insufficiency (VDI) and Vitamin D Deficiency (VDD) is highly prevalent
among Rheumatic Heart Disease (RHD) patients in Nepal. RHD patients presented with sig-
nificantly lower mean s-25(OH)D concentrations and overall poor nutritional status com-
pared to the non-RHD controls. People with Vitamin D insufficiency had a higher risk
(OR = 2.59) of also having RHD, underlining the potential of hypovitaminosis D being either a
risk factor or feature of RHD, but longitudinal studies are needed to explore the causality of
this relationship further. Larger studies among the Nepali population is also recommended to
confirm the high prevalence of hypovitaminosis D found in our control group.
Other potential risk factors found in this study include low BMI, low mid upper arm cir-
cumference, low socioeconomic status, and female sex.
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